ICT Ltd. belongs to pharmaceutical industries. The chemical process that ICT Ltd. operates convert one compound into three category of medicines…

ICT Ltd. belongs to pharmaceutical industries. The chemical process that ICT Ltd. operates convert one compound into three category of medicines viz. BetaTab, Folick and TegriCap. Though BetaTab and Folick are already converted to final product at split-off point, Tegricap needs further processing along with addition of new compound with it. The market for BetaTab and Folick is highly active, thus the production is sold at split-off point, however, Tegricap can be sold only after further processing. Following information is provided for the current year: Products Quantity sold (tons) Selling price per ton (₹) BetaTab 372 7,500 Folick 1,054 5,625 TegriCap 1,472 3,750 The selling price is expected to remain the same for coming years. The total joint manufacturing costs till split-off point is 62,50,000 and the amount spent for further processing w.r.t. Tegricap is 31,00,000 The details regarding closing inventories are as follows: Products Completed units (tons) BetaTab 360 Folick 120 TegriCap 50 You are required to COMPUTE the joint cost allocated to BetaTab, Folick and TegriCap using Net realizable value (NRV) method.